Found 0 matching trials
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations PHASE2 The purpose of this study is to determine if Itacitinib in combination with...
Show More Location
Multiple Locations
Learn More & Join Trial
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease N/A Expanded access use of Itacitinib to treat a single patient with aplastic a...
Show More Location
Multiple Locations
Learn More & Join Trial
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) PHASE1 ABNL-MARRO (A Basket study of Novel therapy for untreated MDS/MPN and Relap...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation PHASE2 This phase II trial studies how well itacitinib works in preventing graft v...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease PHASE2 The purpose of this study is to assess the efficacy and safety of itacitini...
Show More Location
University of Arizona Cancer Center - Out Pt.
Learn More & Join Trial
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma PHASE1 The purpose of this study is to evaluate the safety/tolerability and effica...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis PHASE2 This is a study evaluating a 28-day course followed by a 56-day course of i...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation PHASE1 In this trial, the investigators will begin to explore the possibility that...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia N/A Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic A...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy PHASE2 "The purpose of this study is to assess the safety and efficacy of oral adm...
Show More Location
University of Miami Sylvester Comprehensive Cancer Center
Learn More & Join Trial